Study #2020-0843
Testing of an educational tool for patients with cancer and concomitant autoimmune disease who are candidates for therapy with immune checkpoint inhibitors: Acceptability and Usability with Patients and Providers
MD Anderson Study Status
Enrolling
Treatment Agent
Description
This study learn how easily patients can use an educational tool that will be created for patients with melanoma and pre-existing autoimmune diseases who receive or will receive immune checkpoint inhibitor drugs. Patients will be asked their opinions about the design, accessibility, and content of the tool. Researchers will use the information collected to improve the educational materials that will help patients make future decisions about their treatment.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Ankylosing Spondylitis;Autoimmune Disease;Crohn Disease;Enteropathic Arthritis;Enteropathic Spondylitis;Inflammatory Bowel Disease;Melanoma;Psoriasis;Psoriatic Arthritis;Reactive Arthritis;Rheumatoid Arthritis;Systemic Lupus Erythematosus;Ulcerative Colitis
Study phase:
Physician name:
Maria de los Angeles Lopez-Olivo
Department:
Health Services Research
For general questions about clinical trials:
1-844-285-5619
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.